Clinomics Inc. announced a private placement of series 1 non-guaranteed unsecured private convertible bonds with interest-bearing bonds for a gross proceeds of KRW 30,000,000,000 on July 2, 2021. The transaction will include participation from Renaissance Michelet No. 4 Professional Investment Private Equity Trust for KRW 11,400,000,000, Renaissance KOSDAQ Venture OK Professional Investment Private Equity Trust for KRW 55,000,000, BNB Mezzanine Private Equity Investment Trust No. 2 for KRW 500,000,000, B&B IPO Venture Specialized Investment Type Private Equity Investment Trust No. 4 for KRW 2,500,000,000, K-Clavis KOSDAQ Venture Professional Investment Private Equity Investment Trust No. 2 for KRW 1,500,000,000, Time Folio KOSDAQ Venture It's Time-MS No. 2 Professional Investment Private Equity Trust for KRW 2,000,000,000, Renaissance KOSDAQ Venture Mezzanine Specialized Investment Type Private Equity Trust for KRW 6,100,000,000, Renaissance Active Professional Investment Private Equity Trust for KRW 500,000,000. The bonds will mature on July 7, 2026. The bonds will be 100% converted into 1,919,508 common shares at a fixed conversion price of KRW 15,629 per share for an equity stake of 14.42%. The conversion period is from July 7, 2022 to June 7, 2026. The payment date of the transaction is July 07, 2021. The securities issued in the transaction are subject to a lock up period of one year. The transaction has been approved by the board of directors of the company.